286 Biosafety in Microbiological and Biomedical Laboratories
75. Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al.
Prevention and control of inuenza: recommendations of the Advisory
Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep.
2008;57(RR-7):1–60.
76. Su S, Gu M, Liu D, Cui J, Gao GF, Zhou J, et al. Epidemiology, Evolution,
and Pathogenesis of H7N9 Inuenza Viruses in Five Epidemic Waves since
2013 in China. Trends Microbiol. 2017;25(9):713–28.
77. Pearce MB, Belser JA, Gustin KM, Pappas C, Houser KV, Sun X, et al.
Seasonal trivalent inactivated inuenza vaccine protects against 1918
Spanish inuenza virus infection in ferrets. J Virol. 2012;86(13):7118–25.
78. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-
reactive antibody responses to the 2009 pandemic H1N1 inuenza virus.
N Engl J Med. 2009;361(20):1945–52.
79. Medina RA, Manicassamy B, Stertz S, Seibert CW, Hai R, Belshe RB, et al.
Pandemic 2009 H1N1 vaccine protects against 1918 Spanish inuenza
virus. Nat Commun. 2010;1:28.
80. Science Safety Security [Internet]. Washington (DC): U.S. Department of
Health & Human Services; c2017 [cited 2018 Dec 3]. Dual Use Research of
Concern. Available from: https://www.phe.gov/s3/dualuse/Pages/default.aspx
81. Bowen GS, Calisher CH, Winkler WG, Kraus AL, Fowler EH, Garman RH,
et al. Laboratory studies of a lymphocytic choriomeningitis virus outbreak in
man and laboratory animals. Am J Epidemiol. 1975;102(3):233–40.
82. Jahrling PB, Peters CJ. Lymphocytic choriomeningitis virus. A neglected
pathogen of man. Arch Pathol Lab Med. 1992;116(5):486–8.
83. Knust B, Ströher U, Edison L, Albarino CG, Lovejoy J, Armeanu E,
et al. Lymphocytic Choriomeningitis Virus in Employees and Mice at
Multipremises Feeder-Rodent Operation, United States, 2012. Emerg Infect
Dis. 2014;20(2):240–7.
84. Reiserová L, Kaluzová M, Kaluz S, Willis AC, Zavada J, Zavadska E,
et al. Identication of MaTu-MX Agent as a New Strain of Lymphocytic
Choriomeningitis Virus (LCMV) and Serological Indication of Horizontal
Spread of LCMV in Human Population. Virology. 1999;257(1):73–83.
85. Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, Marty
FM, Comer JA, et al. Transmission of lymphocytic choriomeningitis virus by
organ transplantation. N Engl J Med. 2006;354(21):2235–49.
86. Macneil A, Stroher U, Farnon E, Campbell S, Cannon D, Paddock CD, et
al. Solid organ transplant-associated lymphocytic choriomeningitis, United
States, 2011. Emerg Infect Dis. 2012;18(8):1256–62.